Ladenburg Thalmann Financial Services’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$240K	Sell	3,031 -1,109	-27%	-$65.7K	﹤0.01%	2370
2019 Q3	$202K	Sell	4,140 -828	-17%	-$43.1K	﹤0.01%	2457
2019 Q2	$261K	Buy	4,968 +4,888	+6,110%	+$281K	﹤0.01%	2262
2019 Q1	$4K	Sell	80 -2	-2%	-$98	﹤0.01%	4781
2018 Q4	$3K	Sell	82 -350	-81%	-$13.1K	﹤0.01%	4823
2018 Q3	$17K	Buy	432 +152	+54%	+$6.73K	﹤0.01%	4015
2018 Q2	$14K	Hold	280	–	–	﹤0.01%	4068
2018 Q1	$14K	Sell	280 -5,800	-95%	-$324K	﹤0.01%	4068
2017 Q4	$239K	Buy	6,080 +5,980	+5,980%	+$223K	﹤0.01%	2080
2017 Q3	$3K	Hold	100	–	–	﹤0.01%	4606
2017 Q2	$3K	Buy	+100	New	+$2.98K	﹤0.01%	4517

Other funds holding GBT

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ladenburg Thalmann Financial Services's GBT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Global Blood Therapeutics, Inc. (GBT) stake by 27% in Q4 2019, selling an estimated $65.7K and leaving 3,031 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #2370.

Ladenburg Thalmann Financial Services first reported a position in GBT in Q2 2017 and has held it in 11 quarters since. The position peaked at $261K in Q2 2019. 234 funds tracked by Wall St. Rank hold GBT as of Q4 2019.

Ladenburg Thalmann Financial Services held 3,031 shares of Global Blood Therapeutics, Inc. worth $240K as of Q4 2019.
Ladenburg Thalmann Financial Services sold 1,109 Global Blood Therapeutics, Inc. shares in Q4 2019, an estimated $65.7K.
Global Blood Therapeutics, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2370 holding.
Ladenburg Thalmann Financial Services first reported a position in Global Blood Therapeutics, Inc. in Q2 2017 and has held it in 11 quarters since.
Ladenburg Thalmann Financial Services's Global Blood Therapeutics, Inc. position peaked at $261K in Q2 2019.
234 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.